Results
|
|
3041.
|
Fibroblast growth factor receptor 2 is associated with poor overall survival in clear cell carcinoma of the ovary and may be a novel therapeutic approach. [electronic resource] by
- Itamochi, Hiroaki
- Oumi, Nao
- Oishi, Tetsuro
- Taniguchi, Fuminori
- Shoji, Tadahiro
- Fujiwara, Hiroyuki
- Sugiyama, Toru
- Suzuki, Mitsuaki
- Kigawa, Junzo
- Harada, Tasuku
Producer: 20160201
In:
International journal of gynecological cancer : official journal of the International Gynecological Cancer Society vol. 25
Availability: No items available.
|
|
|
3042.
|
|
|
|
3043.
|
The PI3K/mTOR dual inhibitor NVP-BEZ235 reduces the growth of ovarian clear cell carcinoma. [electronic resource] by
- Oishi, Tetsuro
- Itamochi, Hiroaki
- Kudoh, Akiko
- Nonaka, Michiko
- Kato, Misaki
- Nishimura, Mayumi
- Oumi, Nao
- Sato, Seiya
- Naniwa, Jun
- Sato, Shinya
- Shimada, Muneaki
- Kigawa, Junzo
- Harada, Tasuku
Producer: 20150212
In:
Oncology reports vol. 32
Availability: No items available.
|
|
|
3044.
|
Prospective validation of an intraoperative algorithm to guide surgical staging in early endometrial cancer. [electronic resource] by
- Lefringhouse, Jason R
- Elder, Jeffrey W
- Baldwin, Lauren A
- Miller, Rachel W
- DeSimone, Chris P
- van Nagell, John R
- Samoyoa, Luis M
- West, Dava S
- Dressler, Emily V
- Liu, Meng
- Ueland, Frederick R
Producer: 20170525
In:
Gynecologic oncology vol. 145
Availability: No items available.
|
|
|
3045.
|
|
|
|
3046.
|
|
|
|
3047.
|
|
|
|
3048.
|
|
|
|
3049.
|
Novel mechanism of reduced proliferation in ovarian clear cell carcinoma cells: cytoplasmic sequestration of CDK2 by p27. [electronic resource] by
- Itamochi, Hiroaki
- Yoshida, Tomokazu
- Walker, Cheryl Lyn
- Bartholomeusz, Chandra
- Aoki, Daisuke
- Ishihara, Hideki
- Suzuki, Nao
- Kigawa, Junzo
- Terakawa, Naoki
- Ueno, Naoto T
Producer: 20110926
In:
Gynecologic oncology vol. 122
Availability: No items available.
|
|
|
3050.
|
Efficacy and safety of AEZS-108 (INN: zoptarelin doxorubicin acetate) an LHRH agonist linked to doxorubicin in women with platinum refractory or resistant ovarian cancer expressing LHRH receptors: a multicenter phase II trial of the ago-study group (AGO GYN 5). [electronic resource] by
- Emons, Günter
- Gorchev, Grigor
- Sehouli, Jalid
- Wimberger, Pauline
- Stähle, Anne
- Hanker, Lars
- Hilpert, Felix
- Sindermann, Herbert
- Gründker, Carsten
- Harter, Philipp
Producer: 20140716
In:
Gynecologic oncology vol. 133
Availability: No items available.
|
|
|
3051.
|
|
|
|
3052.
|
Elevated CDCP1 predicts poor patient outcome and mediates ovarian clear cell carcinoma by promoting tumor spheroid formation, cell migration and chemoresistance. [electronic resource] by
- He, Y
- Wu, A C
- Harrington, B S
- Davies, C M
- Wallace, S J
- Adams, M N
- Palmer, J S
- Roche, D K
- Hollier, B G
- Westbrook, T F
- Hamidi, H
- Konecny, G E
- Winterhoff, B
- Chetty, N P
- Crandon, A J
- Oliveira, N B
- Shannon, C M
- Tinker, A V
- Gilks, C B
- Coward, J I
- Lumley, J W
- Perrin, L C
- Armes, J E
- Hooper, J D
Producer: 20160620
In:
Oncogene vol. 35
Availability: No items available.
|
|
|
3053.
|
Loss of autophagy-related protein Beclin 1 may define poor prognosis in ovarian clear cell carcinomas. [electronic resource] by
- Katagiri, Hiroshi
- Nakayama, Kentaro
- Razia, Sultana
- Nakamura, Kohei
- Sato, Emi
- Ishibashi, Tomoka
- Ishikawa, Masako
- Iida, Kouji
- Ishikawa, Noriyoshi
- Otsuki, Yoshiro
- Nakayama, Satoru
- Kyo, Satoru
Producer: 20160907
In:
International journal of oncology vol. 47
Availability: No items available.
|
|
|
3054.
|
|
|
|
3055.
|
|
|
|
3056.
|
|
|
|
3057.
|
|
|
|
3058.
|
|
|
|
3059.
|
|
|
|
3060.
|
|